Wire Stories
PeptiDream Announces Collaboration and License Agreement with MSD for the Discovery and Development of Novel Peptide Drug Conjugates
KANAGAWA, Japan–(BUSINESS WIRE)–#MSD–PeptiDream Inc., a public Kanagawa, Japan-based biopharmaceutical company (President: Patrick C. Reid, hereinafter �PeptiDream�) (Tokyo: 4587) today announced a new...